SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. It also markets PACE systems that use acoustic pressure shockwaves generated by pulsed acoustic cellular expression technology to converge at selected areas for wound and orthopedic applications under the dermaPACE, Profile, and orthoPACE brand names. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Metrics to compare | SNWV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNWVPeersSector | |
---|---|---|---|---|
P/E Ratio | −8.4x | −3.4x | −0.5x | |
PEG Ratio | −0.53 | −0.12 | 0.00 | |
Price/Book | −20.8x | 2.6x | 2.6x | |
Price / LTM Sales | 8.1x | 2.5x | 3.2x | |
Upside (Analyst Target) | - | 36.7% | 42.0% | |
Fair Value Upside | Unlock | 13.9% | 6.6% | Unlock |